Inflammatory bio-markers and cardiovascular risk prediction

Area of Science:

• Cardiovascular Science
• Inflammation Research
• Atherosclerosis Pathogenesis

Background:

• Inflammatory processes are central to atherosclerosis development and complications.
• Plasma inflammatory markers, including C-reactive protein (CRP), correlate with cardiovascular risk.
• Emerging evidence suggests CRP's direct role in atherogenesis, potentially produced within arterial plaques.

Purpose of the Study:

• To review the role of inflammatory markers, especially CRP, in cardiovascular risk.
• To assess CRP's predictive value for cardiovascular events in diverse populations.
• To evaluate the potential of combining inflammatory markers with lipid testing for risk stratification.

Main Methods:

• Review of existing clinical studies and research on inflammatory markers and cardiovascular disease.
• Analysis of associations between plasma CRP levels and cardiovascular risk.
• Examination of CRP's potential direct involvement in atherogenesis.

Main Results:

• Elevated CRP levels are associated with increased risk of myocardial infarction, stroke, peripheral vascular disease, and cardiovascular death.
• CRP is a strong predictor of cardiovascular risk in acute coronary syndromes and apparently healthy individuals.
• Arterial plaque may produce CRP independently of hepatic synthesis.

Conclusions:

• Inflammatory markers, particularly CRP, are significant predictors of cardiovascular risk.
• Integrating CRP measurement with lipid profiles may enhance cardiovascular risk stratification.
• Lifestyle interventions (exercise, weight loss, smoking cessation) are recommended for elevated CRP.
• Further research is needed to confirm statin efficacy in individuals with high CRP levels.